New combo therapy aims to personalize throat cancer treatment
NCT ID NCT07428148
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new approach for people with a certain type of throat cancer that is not low-risk. Participants first receive a combination of chemotherapy, immunotherapy, and a special type of radiation called lattice radiotherapy. Then, based on how much the tumor shrinks, they get either a shorter or longer course of standard chemoradiation. The goal is to see if this personalized plan is safe and effective. About 60 people will take part in this early-phase trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- carboplatin, paclitaxel, pembrolizumab, and lattice radiotherapy
- What this could lead to
- If successful, this could lead to a more personalized, effective treatment for throat cancer that reduces side effects by tailoring radiation dose to how well the tumor responds.
- What could go wrong
- This is an early-phase trial with only 60 participants, so results may not apply to everyone. The combination therapy may cause significant side effects, and the optimal dose is still being determined.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less radiation be safer for throat cancer?
- Can a simple swab predict who needs less radiation?
- New drug combo aims to shrink oral cancers before surgery
- Acupuncture timing may be key to preventing dry mouth in head and neck cancer patients
- New Vaccine-Drug combo aims to tame HPV throat cancer with less radiation
- New pill-chemo combo takes on hard-to-treat cancers